Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG-PDT for Peri-implantitis in Diabetics
NCT04833569Phase 1Completed
- Sponsor
- King Saud University
- Start
- Sep 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of indocyanine green in peri-implantitis (2 arms), sponsored by King Saud University. Primary endpoints: Bleeding on probing at 6 months, Plaque index at 6 months and 3 more. Started Sep 2020; status: completed.
02
Drugs
indocyanine green
03
Conditions
peri-implantitis
Beyond the preview
Go deeper on NCT04833569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04833569.